Friday, 20 November 2026Read the signal. Shape what comes next.
Higher Ed Signal
Get the Signal Brief
Front facade of the ETH Zurich main building under a clear blue sky, with its central portal and columns and a few people walking on the plaza.

Institutional development · Research, innovation and assessment · Switzerland

ETH Zurich reports magnetic microbots that could help clot-dissolving drugs reach target

ETH Zurich has reported work on flow-generating microbots, driven by magnetic fields, that could help medication reach blood clots which restrict flow in vessels.

Photo: Thomas Wolf , www.foto-tw.de / Wikimedia Commons, CC BY-SA 3.0 de

Why it matters: The ETH Zurich work targets cases where a clot restricts blood flow so much that dissolving medication can barely reach it.

ETH Zurich reported on 9 November 2026 on flow-generating microbots intended for use in dissolving blood clots.

According to ETH Zurich, a clot can restrict blood flow in a vessel so severely that drugs meant to break it down can barely reach it.

The university said microbots driven by magnetic fields could offer an unusual solution to this problem.

Editor’s view

Scott James, Research and Innovation Editor

ETH Zurich presents the magnetically driven microbots as a possible way to get clot-dissolving medication to its target when blood flow is restricted, describing the approach as something that could help rather than as an established treatment.

Keep reading

See all